Deutsche Bank Ag\ Aspira Women'S Health Inc. Transaction History

Deutsche Bank Ag\

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$0.4 - $1.09 $1,590 - $4,332	3,975 Added 5.86%	71,818 $42,000
Q1 2022 May 13, 2022	BUY	$0.88 - $1.81 $17,072 - $35,114	19,400 Added 40.05%	67,843 $71,000
Q4 2021 Feb 11, 2022	BUY	$1.63 - $3.43 $3,793 - $7,981	2,327 Added 5.05%	48,443 $86,000
Q3 2021 Nov 04, 2021	SELL	$3.19 - $5.48 $26,142 - $44,908	-8,195 Reduced 15.09%	46,116 $150,000
Q2 2021 Aug 11, 2021	SELL	$4.78 - $6.84 $8,212 - $11,751	-1,718 Reduced 3.07%	54,311 $305,000
Q1 2021 May 13, 2021	SELL	$5.9 - $9.13 $51,719 - $80,033	-8,766 Reduced 13.53%	56,029 $378,000
Q4 2020 Feb 16, 2021	BUY	$3.0 - $6.71 $68,079 - $152,270	22,693 Added 53.9%	64,795 $435,000
Q3 2020 Nov 12, 2020	BUY	$2.54 - $4.56 $45,791 - $82,207	18,028 Added 74.89%	42,102 $130,000
Q2 2020 Aug 13, 2020	BUY	$0.78 - $5.25 $18,777 - $126,388	24,074 New	24,074 $92,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.